Nab-paclitaxel as First Line Treatment for NSCLC in Elderly Patients More Than 75 Years Old

Introduction: Lung cancer is still the leading cause of cancer among cancer patients. Although there are novel therapies as second line treatment for NSCLC, there is an issue for elderly patients. Patients and Methods: We collected retrospectively data from 60 patients >75 years of age. Thirty of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Cancer
Egile Nagusiak: Zarogoulidis, Paul, Huang, Haidong, Bai, Chong, Petridis, Dimitris, Papadopoulou, Susana, Faniadou, Eleni, Eleftheriadou, Ellada, Trakada, Georgia, Cristoforos, Kosmidis, Rapti, Aggeliki, Yarmus, Lonny, Kopman, David-Feller, Man, Yan-Gao, Hohenforst-Schmidt, Wolfgang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ivyspring International Publisher 2017
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5535723/
https://ncbi.nlm.nih.gov/pubmed/28775787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.19463
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak